Melbourne-based Alkira Bio, a novel drug discovery platform company, has announced an investment from US venture capital firm Curie.Bio.
Florey biotech spin-out secures seed investment from Curie.Bio
July 8, 2024 Latest NewsAustralian BiotechLatest Video
New Stories
-
Cabinet documents reveal decades-old focus on faster PBS listings
January 24, 2025 - - Latest News -
No probity advisor but what about a form of confidentiality deed?
January 24, 2025 - - Latest News -
CEPI backing for Vaxxas to advance needle-free thermostable mRNA vaccines
January 23, 2025 - - Latest News -
New preventive treatments could support ongoing fight against COVID
January 23, 2025 - - Latest News -
Pharmac encourages input on on multiple medicines funding proposal
January 22, 2025 - - Latest News -
Immutep completes patient enrolment for EFTISARC-NEO Phase 2 trial
January 22, 2025 - - Australian Biotech -
Emyria announces key leadership changes
January 22, 2025 - - Latest News